Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 6, 2026, 2:14 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 121–144 of 7,404 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: Tissue specimen Clear all

Conditions: Rectal Adenocarcinoma, Stage II Rectal Cancer AJCC v8, Stage IIA Rectal Cancer AJCC v8, Stage IIB Rectal Cancer AJCC v8, Stage IIC Rectal Cancer AJCC v8, Stage III Rectal Cancer AJCC v8, Stage IIIA Rectal Cancer AJCC v8, Stage IIIB Rectal Cancer AJCC v8, Stage IIIC Rectal Cancer AJCC v8
Interventions: Biopsy, Biospecimen Collection, Electronic Health Record Review; Procedure · Other
Lead sponsor: OHSU Knight Cancer Institute; Other
Eligibility: 18 Years and older
Enrollment: 50 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2027
U.S. locations: 2
States / cities: Portland, Oregon • Seattle, Washington

Conditions: Stress Urinary Incontinence, Urinary Incontinence, Mixed Urinary Incontinence
Interventions: Solyx Single-incision Sling, Bulkamid Transurethral Bulking Agent; Device
Lead sponsor: NICHD Pelvic Floor Disorders Network; Network
Eligibility: 21 Years and older · Female only
Enrollment: 358 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2030
U.S. locations: 7
States / cities: La Jolla, California • San Diego, California • Chicago, Illinois + 4 more

Conditions: Pain Measurement
Interventions: Alfentanil, Propranolol, Placebo; Drug
Lead sponsor: Martin Angst; Other
Eligibility: Not listed
Enrollment: 10 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2010
U.S. locations: 1
States / cities: Stanford, California

Conditions: Sickle Cell Disease
Interventions: Hematopoietic Stem Cell Transplantation, CliniMACS, See intervention description; Procedure · Device · Drug
Lead sponsor: St. Jude Children's Research Hospital; Other
Eligibility: 2 Years to 16 Years
Enrollment: 5 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2005 – 2009
U.S. locations: 1
States / cities: Memphis, Tennessee

Conditions: Sarcoma, Soft Tissue, Soft Tissue Sarcoma
Interventions: Pazopanib; Drug
Lead sponsor: Washington University School of Medicine; Other
Eligibility: 18 Years and older
Enrollment: 56 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2020
U.S. locations: 7
States / cities: Phoenix, Arizona • Jacksonville, Florida • Chicago, Illinois + 4 more

Conditions: Pancreatic Diseases
Interventions: Somatostatin analog; Drug
Lead sponsor: Mayo Clinic; Other
Eligibility: 18 Years and older
Enrollment: 103 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2027
U.S. locations: 1
States / cities: Rochester, Minnesota

Conditions: Breast Cancer, Cancer of Breast, Cancer of the Breast
Interventions: Breast-conserving surgery (BCS), Cavity shave margins (CSM), BREAST-Q Questionnaire, 3-D breast imaging, Indocyanine green, Intraoperative imaging device, Peripheral blood draw; Procedure · Behavioral · Device + 1 more
Lead sponsor: Washington University School of Medicine; Other
Eligibility: 18 Years to 85 Years · Female only
Enrollment: 81 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2019
U.S. locations: 1
States / cities: St Louis, Missouri

Conditions: Prostate Cancer
Interventions: VMCore Biopsy System, Standard of Care Biopsy Needle; Device
Lead sponsor: Uro-1 Medical; Industry
Eligibility: 18 Years and older · Male only
Enrollment: 40 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2022
U.S. locations: 1
States / cities: Cartersville, Georgia

Conditions: Multiple System Atrophy, Parkinsons Disease
Interventions: Sural Nerve Graft to the Substantia Nigra, Sham surgery; Procedure
Lead sponsor: Craig van Horne, MD, PhD; Other
Eligibility: 40 Years to 75 Years
Enrollment: 7 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2030
U.S. locations: 1
States / cities: Lexington, Kentucky

Conditions: Nasal Obstruction
Interventions: Vivaer Stylus; Device
Lead sponsor: Aerin Medical; Industry
Eligibility: 22 Years to 75 Years
Enrollment: 50 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2017
U.S. locations: 9
States / cities: Fresno, California • Colorado Springs, Colorado • Oradell, New Jersey + 6 more

Conditions: Low Back Pain
Interventions: Soft Tissue, Myofascial release, Counterstrain, Muscle energy, Sacro-iliac articulation, High-velocity, low amplitude; Procedure
Lead sponsor: University of North Texas Health Science Center; Other
Eligibility: 17 Years to 35 Years
Enrollment: 100 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2006 – 2007
U.S. locations: 1
States / cities: Fort Lewis, Washington

Conditions: Dermatomyositis, Polymyositis
Interventions: Acthar; Drug
Lead sponsor: Phoenix Neurological Associates, LTD; Other
Eligibility: 18 Years to 85 Years
Enrollment: 100 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: Started 2013
U.S. locations: 5
States / cities: Phoenix, Arizona • San Diego, California • Columbia, Missouri + 2 more

Conditions: Systemic Lupus Erythematosus
Interventions: PET/CT, Pioglitazone, Placebo; Radiation · Drug
Lead sponsor: National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS); NIH
Eligibility: 18 Years to 99 Years
Enrollment: 88 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2020
U.S. locations: 1
States / cities: Bethesda, Maryland

Conditions: Cognitive Dysfunction
Interventions: Transcranial Magnetic Stimulation (TMS); Device
Lead sponsor: University of Arizona; Other
Eligibility: 60 Years to 75 Years
Enrollment: 40 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2018 – 2020
U.S. locations: 1
States / cities: Tucson, Arizona

Conditions: Cellulite
Interventions: cryolipolysis, Subcision, Control; Device · Procedure · Other
Lead sponsor: Northwestern University; Other
Eligibility: 18 Years to 60 Years
Enrollment: 22 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2010 – 2011
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Vascular Graft Infection
Interventions: Prophylactic muscle flap; Procedure
Lead sponsor: University of Wisconsin, Madison; Other
Eligibility: 18 Years and older
Enrollment: 5 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2021
U.S. locations: 1
States / cities: Madison, Wisconsin

Conditions: Healthy Volunteers
Interventions: Growth Hormone Releasing Hormone (Tesamorelin); Drug
Lead sponsor: Massachusetts General Hospital; Other
Eligibility: 18 Years to 60 Years · Male only
Enrollment: 15 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2009 – 2010
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Osteosarcoma
Interventions: Cytology Specimen Collection Procedure; Other
Lead sponsor: Children's Oncology Group; Network
Eligibility: Not listed
Enrollment: 957 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2023
U.S. locations: 160
States / cities: Birmingham, Alabama • Phoenix, Arizona • Little Rock, Arkansas + 116 more

Conditions: MRSA
Interventions: Not listed
Lead sponsor: Children's Healthcare of Atlanta; Other
Eligibility: 6 Months to 21 Years
Enrollment: 50 participants
Timeline: 2019 – 2020
U.S. locations: 1
States / cities: Atlanta, Georgia

Conditions: Cancer Head Neck, Metastatic Cancer, Metastatic Lung Cancer
Interventions: adnectin 18F-BMS-986192 Head and Neck Cancer, adnectin 18F-BMS-986192 Brain Metastases; Drug
Lead sponsor: Yale University; Other
Eligibility: 18 Years and older
Enrollment: 7 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2024
U.S. locations: 1
States / cities: New Haven, Connecticut

Conditions: HIV Infections
Interventions: 5-aminosalicylic acid; Drug
Lead sponsor: National Institute of Allergy and Infectious Diseases (NIAID); NIH
Eligibility: 18 Years to 65 Years · Male only
Enrollment: 14 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: Started 1999
U.S. locations: 1
States / cities: Los Angeles, California

Conditions: Breast Cancer, Mastectomy
Interventions: AlloDerm RTU, SurgiMend PRS; Device
Lead sponsor: University of Pittsburgh; Other
Eligibility: 18 Years and older · Female only
Enrollment: 9 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2015
U.S. locations: 1
States / cities: Pittsburgh, Pennsylvania

Conditions: Muscle Atrophy
Interventions: Massage; Other
Lead sponsor: Esther Dupont-Versteegden; Other
Eligibility: 18 Years to 30 Years
Enrollment: 44 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2020 – 2023
U.S. locations: 1
States / cities: Lexington, Kentucky

Conditions: Ovarian Autotransplantation Using Cryopreserved Ovarian Tissue in Women Treated for Cancer
Interventions: Ovarian autotransplantation; Procedure
Lead sponsor: Samuel Kim, MD; Other
Eligibility: 18 Years to 40 Years · Female only
Enrollment: 1 participant
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2014
U.S. locations: 1
States / cities: Kansas City, Kansas

Search by objective public record fields.

Establishing a ctDNA Biomarker to Improve Organ Preserving Strategies in Patients With Rectal Cancer

Trial of Transurethral Bulking Agent Injection Versus Single-Incision Sling for Stress Urinary Incontinence

Evaluation of Propranolol's Effect on Pain and Inflammation.

Haploidentical Stem Cell Transplant for Patients With Sickle Cell Disease and Prior Stroke or Abnormal Transcranial Ultrasound

Pazopanib as Front-Line Therapy in Patients With Non-Resectable or Metastatic Soft Tissue Sarcomas Who Are Not Candidates for Chemotherapy

Somatostatin Analogues With Perioperative Antibiotics Versus Prolonged Antibiotics

Shave Margins in Breast Conservation Therapy

Assessment of VMCore Biopsy Versus Standard of Care Biopsy

Autologous suraL nervE Grafting to the Substantia nigrA in Patients With Synuclienopathies

Treatment of Nasal Airway Obstruction Using the Aerin Medical Device

How Does Manual Therapy Improve Low Back Pain for Soldiers?

Dermatomyositis and Polymyositis Registry

Role of PPAR-y Agonists in Immunomodulation and Vascular Prevention in SLE (PPAR-SLE)

Probing Cortical Excitability and Cognitive Function With TMS

Cryolipolysis and Subcision for Treatment of Cellulite

Prophylactic Muscle Flaps in Vascular Surgery

Effect of Short Term Growth Hormone Releasing Hormone in Healthy Men

Collecting and Storing Samples of Blood and Tumor Tissue From Patients With Osteosarcoma

Surveillance of Community-Associated MRSA

Non-invasive Measurement of PD-L1 Levels With Positron Emission Tomography (PET) in Head and Neck Malignancies and Intracranial Metastases

Effect of an Anti-Inflammatory Drug on Gut Mucosa in HIV Infected Patients

Acellular Dermal Matrix in Tissue Expander Breast Reconstruction: A Prospective, Randomized, Clinical Trial Comparing SurgiMend PRS and AlloDerm RTU

Mechanisms Underlying Local and Systemic Effects of Massage

Human Ovarian Autotransplantation